Medication info
Jardiance Duo Tablet 12.5/850 mg

Jardiance Duo Tablet 12.5/850 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›850mg / 1 tablet
Manufacturer / importer
Boehringer Ingelheim Korea
Appearance
Pinkish-white, oval, biconvex film-coated tablet
Packaging
60 tablets/box [10 tablets/PTP × 6 packs]
Approval status
Active

MFDS item code 201600389 · Approved 2016.01.21 · Insurance code 653501510

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Importer
Boehringer Ingelheim Korea

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Abnormal glycemic control in adult patients with type 2 diabetes
  • cardiovascular disease
View approved original text

This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. In particular, this drug helps in glycemic control with the combination of empagliflozin and metformin. Additionally, in patients with insufficient blood sugar control and cardiovascular disease, caution should be exercised regarding the impact of this medication on cardiovascular events. Therefore, this medication is prescribed for adult type 2 diabetes patients considering both blood sugar management and cardiovascular health.

How to take

Adult dose

The recommended dose of this medication is 1 tablet per dose, 2 times daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medications such as insulin, the recommended dose is empagliflozin 5 mg 2 times daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medication from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medication is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medication should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If a dose of this medication is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medication contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medication is 1000 mg, given as 500 mg 2 times daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, discontinue this medication immediately (see Precautions for Use 2. Patients in Whom This Medication Is Contraindicated, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps to control blood sugar. However, several important precautions must be followed while taking this medication. First, this medication can cause a rare but very serious side effect known as lactic acidosis. Lactic acidosis is a condition that occurs when there is an excessive buildup of lactic acid in the body, which can present symptoms such as difficulty breathing, muscle pain, fatigue, and abdominal pain. If these symptoms occur, you should immediately consult a physician. Second, when used with other diabetes medications or insulin, hypoglycemia may occur, so blood glucose levels should be monitored frequently, and medication dosages should be adjusted according to medical advice. Third, patients with impaired kidney function, acute kidney issues, severe dehydration, severe infection, or heart problems should not take this medication, and those about to undergo surgery should temporarily suspend its usage. Fourth, this medication may increase the risk of urinary tract infections and genital infections, so symptoms of infection should be reported to a healthcare professional immediately. Fifth, there may be a reduction in vitamin B12 levels, so regular blood tests are advised for long-term users. Sixth, it is safest for pregnant women, women who may become pregnant, and nursing mothers not to take this medication. Seventh, elderly patients or those at risk for fluid loss should be vigilant for dehydration symptoms and monitor fluid status and adjust medication use if necessary. Finally, it is advisable to avoid alcohol intake while taking this medication, and if any sudden unusual symptoms or changes in health occur, consult a physician immediately.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 175 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • taste disturbance
  • itching
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipid
  • increased serum creatinine
  • decreased glomerular filtration rate
  • vulvovaginitis
  • vulvitis
  • balanitis
  • necrotizing fasciitis of the perineum
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • maxillofacial fracture
  • musculoskeletal pain
  • myocardial infarction
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • necrotizing fasciitis of the perineum
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • headache
  • orthostatic dizziness
  • dizziness
  • asthenia
  • chest discomfort
  • chest pain
  • fever
  • facial swelling
  • chills
  • strange feeling
  • edema
  • pain
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight loss
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • insomnia
  • anxiety
  • neuralgia
  • orthostatic vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • nasopharyngitis
  • herpes zoster
  • drowsiness
  • chest discomfort
  • weight gain
  • ECG abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive urine red blood cells
  • ureterolithiasis
  • acute kidney injury
  • chronic kidney disease
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • cervical inflammation
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • somnolence
  • hyperlipidemia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival injection
  • retinal crystal formation
  • retinal vein occlusion
  • macular detachment
  • swelling of the eyelid
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual sputum
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it should be kept at room temperature between 1°C and 30°C. Avoid storage in excessively hot or cold places.

Appearance and packaging

Appearance

Pinkish-white, oval, biconvex film-coated tablet

Package unit

60 tablets/box [10 tablets/PTP × 6 packs]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.